PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 7, 2026Cell Discovery0 citationsOpen Access

ASB7 promotes osteosarcoma lung metastasis through ubiquitin-mediated degradation of ATF2

View Full Paper
YZYezi ZouJZJianliang ZhongLHLanqing Huo

Key Points

  • The study aims to explore the role of ASB7 in osteosarcoma metastasis mechanisms.
  • Investigation of ASB7's role in tumor cell behavior like invasion and migration.
  • Analysis of ASB7's interaction with CUL5 and ATF2.
  • Assessment of ITGB2 expression levels and its regulatory pathways.
  • ASB7 promotes lung metastasis in osteosarcoma through the degradation of ATF2.
  • High ASB7 levels correlate with poor patient prognosis.
  • Elevation of ITGB2 enhances metastatic potential in lung tissues.

Abstract

Abstract Osteosarcoma is a highly heterogeneous and aggressive malignancy with a strong propensity for metastasis, highlighting the need to define its molecular drivers. Here, we report that ASB7 promotes tumor cell protrusion formation, invasion, migration, and lung metastasis. High expression of ASB7 is correlated with a poor prognosis. ASB7 forms an E3 ubiquitin ligase complex with CUL5 to ubiquitinate ATF2 at K383 and promote its proteasomal degradation. ATF2 reduction impairs HDAC6 recruitment to the ITGB2 promoter, thereby alleviating the transcriptional repression of ITGB2. Elevated ITGB2 expression subsequently promotes tumor lung metastasis. Our findings reveal that the ASB7-ATF2/HDAC6-ITGB2 axis regulates osteosarcoma metastasis and suggest potential treatment targets.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zou et al. (2026) studied this question.

synapsesocial.com/papers/69fbef68164b5133a91a3475https://doi.org/10.1038/s41421-026-00890-9
Ask AI
Helpful
Bookmark
Share
View Full Paper